Insmed Inc (FRA:IM8N)
€ 66.5 -1 (-1.52%) Market Cap: 11.45 Bil Enterprise Value: 11.43 Bil PE Ratio: 0 PB Ratio: 308.84 GF Score: 61/100

Insmed Inc at Goldman Sachs Healthcare Conference Transcript

Jun 14, 2023 / 08:20PM GMT
Release Date Price: €17.9 (-2.19%)
Andrea R. Tan
Goldman Sachs Group, Inc., Research Division - Research Analyst

Perfect. Thanks, everyone, for joining us. Andrea Tan, biotech analyst at Goldman Sachs. She we're pleased to have Will Lewis, CEO of Insmed with us. Thanks again, Will, for joining us.

William H. Lewis
Insmed Incorporated - President, CEO & Chairman

Glad to be here.

Questions & Answers

Andrea R. Tan
Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe if we can start big picture. Insmed, 4 pillars, very, very active. Maybe walk us through a high-level overview of each of those pillars, the progress you're making there and then the expectations for these key data reads that are coming from each one.

William H. Lewis
Insmed Incorporated - President, CEO & Chairman

Sure. I think the next 12 months is probably the most exciting time in the history of the company, and I've been at the company now coming up on 11 years. We've really spent the last several years

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot